Skip to content
OpenCapital
Get started

Biodesix, Inc. BDSX Development Services — Revenue

Other product segments

Diagnostic Tests
$22.29M+36.6%

Similar metrics at other companies

Simulations Plus logo
SLPDevelopment — Revenue
$18.86M+12.0%
GRAIL, Inc. logo
GRALDevelopment Services — Total Revenue
$953K-64.8%
Kura Oncology logo
KURADevelopment Services In Combination With Other Therapies — Revenue
$5.3M—
AMP
AMPHResearch And Development Services — Revenue
$2.5M+2,400%
Arcus Biosciences logo
RCUSLicense and development services — Total revenues
$12M-40.0%
Ondas, Inc. logo
ONDSDevelopment Revenue — Revenue
$2.43M+1,031%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%—
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s development services — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s development services — revenue?
Biodesix, Inc. (BDSX) reported development services — revenue of $3.26M in Q1 2026.
How has Biodesix, Inc.'s development services — revenue changed year-over-year?
Biodesix, Inc.'s development services — revenue increased by 98.8% year-over-year, from $1.64M to $3.26M.
What is the long-term trend for Biodesix, Inc.'s development services — revenue?
Over 2 years (2023 to 2025), Biodesix, Inc.'s development services — revenue has grown at a 54.5% compound annual growth rate (CAGR), from $3.9M to $9.3M.
What does development services — revenue mean?
This metric represents the total revenue recognized from providing diagnostic research, clinical trial testing, and companion diagnostic development services to biopharmaceutical partners. It reflects the commercial success and market demand for the company's specialized laboratory and development capabilities within the lung disease diagnostic space.